Koninklijke Philips N.V.
NYSE:PHGMedical - Devices
+$0.57 today
- Market cap
- $29.11B
- Beta
- 0.93
- P/E (TTM)
- 23.1
- EPS (TTM)
- $1.02
- Dividend yield
- 3.62%
Volume 1.45M
Average 1.17M
PHG Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Koninklijke Philips N.V.NYSE: PHG
Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026
Depreciation & amortization grows, but more slowly than its trailing trend
Q2 FY2026 depreciation & amortization of €381M rose 43.2% year over year, behind the +68.7% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 43.8% from the prior quarter. Over 3 fiscal years it compounded at -11.1% a year.
Context
- Depreciation & amortization amounted to 6.3% of revenue in FY2025, down 1.4 pp from a year earlier.
- Depreciation & amortization increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +43.2% toward the trailing-twelve-month pace of +68.7%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
EUR · from the income statement
- Latest · FY2025
- 1.13B EUR
- Year-over-year change
- -19.0%
- 4-year CAGR
- -4.0%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.13B | -19.0% |
| FY2024 | 2024-12-31 | 1.39B | +10.2% |
| FY2023 | 2023-12-31 | 1.26B | -21.3% |
| FY2022 | 2022-12-31 | 1.6B | +21.1% |
| FY2021 | 2021-12-31 | 1.32B | — |
Depreciation & Amortization vs competitors
How PHG compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +68.7% is the 2nd highest of 10, against a peer median of +2.2%.
- Depreciation & amortization amounts to 7.0% of revenue for PHG, versus a peer median of 4.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $2.94B USD | -0.3% | +3.1% | 7.8% | |
| LTM Sep 2026 | $2.54B USD | -19.0% | -1.6% | 5.3% | |
| LTM Jun 2026 | $1.41B USD | +7.5% | +6.4% | 6.7% | |
| LTM Jun 2026 | €1.23B EUR | +68.7% | -11.1% | 7.0% | |
| LTM Jun 2026 | $607M USD | +7.1% | -3.0% | 3.0% | |
| FY2025 | $459M USD | +2.2% | -2.3% | 7.4% | |
| LTM Jun 2026 | $244.15M USD | +3.5% | +7.3% | 4.3% | |
| LTM Sep 2026 | $48.5M USD | -15.7% | -10.1% | 3.2% | |
| LTM Mar 2026 | $2.05M USD | +160.3% | +52.5% | 2.4% | |
| LTM Mar 2026 | $1.57M USD | -13.4% | -13.3% | 1.6% | |
| Peer median (excluding PHG) | — | +2.2% | -1.6% | 4.3% | |
Competitors are the stored peer set for PHG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 17.16B | 17.83B | 18.17B | 18.02B | 17.83B |
| Cost of Revenue | 9.99B | 10.63B | 10.72B | 10.25B | 9.78B |
| Gross Profit | 7.17B | 7.19B | 7.45B | 7.77B | 8.06B |
| Gross Margin | 41.8% | 40.4% | 41.0% | 43.1% | 45.2% |
| Research & Development | 1.81B | 2.09B | 1.89B | 1.75B | 1.7B |
| Selling, General & Admin | 4.86B | 5.29B | 5.13B | 5.07B | 4.97B |
| Operating Expenses | 6.62B | 8.72B | 7.56B | 7.24B | 6.63B |
| Depreciation & Amortization | 1.32B | 1.6B | 1.26B | 1.39B | 1.13B |
| EBITDA | 2B | 115M | 1.04B | 1.85B | 2.64B |
| EBITDA Margin | 11.6% | 0.6% | 5.7% | 10.3% | 14.8% |
| Operating Income | 553M | (1.53B) | (115M) | 529M | 1.42B |
| Operating Margin | 3.2% | -8.6% | -0.6% | 2.9% | 8.0% |
| Interest Income | 18M | 25M | 46M | 79M | 108.54M |
| Interest Expense | 164M | 244M | 306M | 337M | 332.34M |
| Other Income / Expenses | (44M) | (202M) | (412M) | (406M) | (242M) |
| Income Before Tax | 509M | (1.73B) | (527M) | 123M | 1.18B |
| Pre-Tax Margin | 3.0% | -9.7% | -2.9% | 0.7% | 6.6% |
| Income Tax Expense | (103M) | (113M) | (73M) | 963M | 282M |
| Net Income | 3.32B | (1.61B) | (466M) | (702M) | 895M |
| Net Margin | 19.3% | -9.0% | -2.6% | -3.9% | 5.0% |
| EPS (Basic) | 0.67 | (1.68) | (0.49) | (0.75) | 0.95 |
| EPS (Diluted) | 0.64 | (1.68) | (0.49) | (0.75) | 0.93 |
| Weighted Avg Shares | 907.46M | 952.46M | 948.79M | 933.37M | 962.37M |
| Weighted Avg Shares (Diluted) | 950.28M | 952.46M | 948.79M | 933.37M | 962.5M |
Koninklijke Philips N.V.
NYSE:PHG
Intrinsic Alpha fair value
Locked
Current Price
$29.81
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.